Core Insights - Boston Properties (BXP) reported revenue of $809.15 million for the quarter ended December 2025, reflecting a year-over-year increase of 1.4% but a revenue surprise of -0.68% compared to the Zacks Consensus Estimate of $814.66 million [1] - The company's EPS was $1.56, significantly higher than the $0.49 reported in the same quarter last year, but fell short of the consensus estimate of $1.80, resulting in an EPS surprise of -13.52% [1] Financial Performance Metrics - The occupancy rate of in-service properties was reported at 86.7%, slightly exceeding the average estimate of 86.3% from three analysts [4] - Revenue from parking and other services, including insurance proceeds, was $42.88 million, surpassing the average estimate of $35.1 million from five analysts, marking a year-over-year increase of 25.9% [4] - Revenue from development and management services was $8.64 million, slightly below the average estimate of $9.04 million from five analysts, representing a year-over-year decrease of 1.6% [4] - Hotel revenue was reported at $12.46 million, which was lower than the average estimate of $13.71 million from four analysts, indicating a year-over-year decline of 5.2% [4] - The lease revenue of $809.15 million was compared to the average estimate of $814.61 million based on four analysts, showing a year-over-year increase of 1.4% [4] - The diluted net earnings per share were reported at $1.56, significantly higher than the average estimate of $0.59 from five analysts [4] Stock Performance - Over the past month, shares of Boston Properties have returned -6.1%, contrasting with a +0.4% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Viewpoint - Alexandria Real Estate Equities, Inc. has initiated cash tender offers to purchase up to $800,000,000 of its outstanding senior notes, which include 3.000% Senior Notes due 2051, 3.550% Senior Notes due 2052, and 4.000% Senior Notes due 2050 [1][4] Group 1: Tender Offer Details - The tender offers are open to all registered holders of the notes and are subject to the conditions outlined in the Offer to Purchase dated January 27, 2026 [4] - The company reserves the right to adjust the Aggregate Maximum Tender Amount at any time without extending withdrawal rights, except as required by law [4] - The total consideration for each series of notes will include an early tender premium of $50 per $1,000 principal amount if tendered by the Early Tender Date of February 9, 2026 [5][6] Group 2: Acceptance Priority and Conditions - Notes will be accepted based on their Acceptance Priority Levels, with higher priority notes being accepted before lower priority ones [7] - If the tender offers are fully subscribed by the Early Tender Date, notes tendered after this date will not be accepted for purchase [8] - The company's obligation to accept notes is contingent upon receiving at least $500,000,000 from other capital market financing transactions [9] Group 3: Financial and Operational Context - Alexandria Real Estate Equities, Inc. is a leading life science REIT, recognized for its role in developing collaborative ecosystems in key life science innovation clusters [11] - The company has been operational since 1994 and is noted for its long-standing presence in the life science real estate sector [11]

Core Viewpoint - Ashford Hospitality Trust, Inc. has announced the tax reporting information for its preferred share distributions for the year 2025, detailing the amounts and tax treatment for each series of preferred stock [1][2]. Distribution Details - The preferred distributions were paid on January 15, 2025, to stockholders of record as of December 31, 2024, and are reportable in 2025 [2]. - The distributions per share for various series are as follows: - Series D: $2.1124 - Series F: $1.8436 - Series G: $1.8436 - Series H: $1.8750 - Series I: $1.8750 - Series J: $2.0000 (multiple CUSIPs) - Series K: Ranging from $2.0667 to $2.1042 - Series L: Ranging from $0.3125 to $1.2500 - Series M: Ranging from $0.3208 to $1.2834 [3][4]. Tax Reporting - The company will post Form 8937, which provides detailed information on the return of capital amount of the preferred share distributions, on its website [5]. - Stockholders are encouraged to consult with their tax advisors regarding the tax implications of these dividends [5]. Company Overview - Ashford Hospitality Trust is a real estate investment trust (REIT) that primarily invests in upper upscale, full-service hotels [6].

Core Viewpoint - Whitestone REIT has announced the federal income tax treatment of its 2025 cash distributions to common shareholders, detailing the classifications for tax reporting purposes [1] Group 1: Cash Distributions - The total cash distribution per share for 2025 is $0.540000, with ordinary dividends amounting to $0.445560 and an unrecaptured capital gain distribution of $0.094440 [1] - Each monthly distribution from January to December 2025 is set at $0.045000 per share, with ordinary dividends consistently at $0.037130 and unrecaptured capital gains at $0.007870 [1] Group 2: Company Overview - Whitestone REIT is a community-centered real estate investment trust that focuses on acquiring, owning, operating, and developing open-air retail centers in rapidly growing markets such as Phoenix, Austin, Dallas-Fort Worth, Houston, and San Antonio [2] - The company emphasizes convenience-focused centers that host a mix of service-oriented tenants, including food, self-care, services, education, and entertainment [3]

Core Insights - The company reported a leasing volume of 1.2 million square feet, which is a 14% increase compared to the prior four-quarter average and a 10% increase compared to the prior eight-quarter average [1] - The fourth quarter of 2025 saw a diluted FFO per share of $2.16, aligning with the company's prior guidance, and a full-year FFO of $9.01 [2] - Management's focus for 2026 includes timely execution, prioritizing dispositions, balance sheet flexibility, and reducing capital expenditures [3][7] Leasing Performance - The company achieved a total leasing volume of 1.2 million square feet in Q4 2025, marking the highest quarterly leasing volume in the last year [2][6] - Vacant space leasing totaled 393,000 rentable square feet, nearly double the quarterly average over the last five quarters [1] - Occupancy at the end of 2025 was 90.9%, up 30 basis points sequentially [8] Financial Performance - The company executed $1.5 billion in dispositions across 26 transactions during Q4 2025 [2][6] - Same-property net operating income (NOI) declined by 6% in Q4 and 3.5% for the full year, with expectations of an 8.5% decline in 2026 [11] - The company recognized $1.45 billion in impairments in Q4, primarily related to land [16] 2026 Outlook - Management anticipates occupancy to dip in early 2026 due to approximately 1.2 million square feet of lease expirations, with a recovery expected in the second half of the year [5][9] - The company has set a disposition target of $2.9 billion for 2026, with 65% to 75% expected to come from non-core assets [7][15] - Capitalized interest is projected to decline by 24% to $250 million in 2026 [13] Market Conditions - The leasing environment remains cautious, particularly in the biotech sector, with venture capital funding at its lowest in a decade [21][22] - Smaller spaces under 50,000 square feet are active, but there is a lack of public biotech tenants in the 50,000 to 150,000 square foot range [22] - Free rent levels have been increasing, indicating weakening fundamentals in the leasing market [23]

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Makarora Management LP (“Makarora”) today announced that, together with Ares Alternative Credit funds (“Ares”), it has completed the previously announced acquisition of Plymouth Industrial REIT, Inc. (“Plymouth”) in an all-cash transaction valued at approximately $2.1 billion. Pursuant to the terms of the transaction, Plymouth shareholders will receive cash consideration of $22.00 per share. With the completion of the acquisition, Plymouth will no longer be traded ...

Financial Data and Key Metrics Changes - For Q4 2025, the diluted FFO per share was $2.16, and for the full year, it was $9.01, aligning with the midpoint of prior guidance [7] - Same property net operating income (NOI) decreased by 6% for Q4 and 3.5% for the full year, with a cash basis decline of 1.7% for Q4 and an increase of 0.9% for the full year [10][11] - Occupancy at the end of 2025 was 90.9%, up 30 basis points from the previous quarter and 10 basis points above prior guidance [9] Business Line Data and Key Metrics Changes - The company completed $1.5 billion in dispositions across 26 transactions and achieved a total leasing volume of 1.2 million sq ft in Q4, the highest in the last year [7] - Leasing of vacant space in Q4 reached 393,000 rentable sq ft, nearly double the average over the last five quarters [8] - The average lease term for the quarter was just over 7.5 years, consistent with the prior three-year average [8] Market Data and Key Metrics Changes - The company noted that its mega campuses, which account for about 78% of annual rental revenue, outperformed total market occupancy in the largest three markets by 19% [9] - The leasing volume for private biotechnology made up about a fifth of all leasing volume in Q4, indicating sustained demand from this segment [66] Company Strategy and Development Direction - The company plans to focus on timely execution of its strategic plan for 2026, emphasizing dispositions, maintaining a strong balance sheet, and reducing capital expenditures [5] - The strategic path forward includes reducing the size of the pipeline and construction spending needs, with a goal to complete a large-scale non-core disposition plan in 2026 [16][20] - The company aims to recycle capital from dispositions and partial interest sales to support funding needs, particularly focusing on non-core assets and land [22][23] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding the leasing environment, noting that while there are positive signs in venture capital funding, decision-making remains conservative among companies [31][32] - The company anticipates a dip in occupancy in Q1 2026 due to key lease expirations but expects growth in the second half of 2026 [10] - Management reiterated that the public biotech sector's recovery is critical for future leasing demand, as many companies currently have sufficient space [76][78] Other Important Information - The company achieved significant general and administrative cost savings of $51.3 million, or 30% compared to the prior year, with G&A costs as a percentage of NOI at 5.6% for 2025 [15] - The company has a strong balance sheet with liquidity of $5.3 billion and a net debt to adjusted EBITDA ratio of 5.7x for Q4 [18] Q&A Session Summary Question: Impact of VC funding on leasing outlook - Management noted that while there is sustained funding in private biotechnology, the overall environment remains cautious, and decision-making is taking longer [30][32] Question: Strategy regarding The Fenway office property - Management confirmed that retaining The Fenway office property for leasing as office space is a strategic decision based on demand [34][35] Question: Cap rate trends for dispositions - Management indicated that cap rates for non-core assets are in the mid-sixes to mid-nines, depending on market conditions and asset specifics [40] Question: Guidance for FFO in Q4 2026 - Management confirmed that the guidance for Q4 2026 FFO remains at $1.40-$1.60, representing a trough for the year [48][49] Question: Buyer types for dispositions - Management highlighted that the buyer pool includes investment funds and residential developers, with a significant portion of land expected to be sold for residential use [56][57] Question: Capital allocation priorities - Management stated that the priority is on debt reduction through the disposition program before considering stock buybacks [85]

Financial Data and Key Metrics Changes - FFO per share diluted as adjusted was $2.16 for Q4 2025 and $9.01 for the year, aligning with prior guidance [5] - Same property net operating income (NOI) decreased by 6% for Q4 and 3.5% for the full year 2025 [8][10] - Occupancy at the end of 2025 was 90.9%, up 30 basis points from the prior quarter [7] Business Line Data and Key Metrics Changes - Leasing volume for Q4 was 1.2 million sq ft, up 14% over the prior four-quarter average [6] - The leasing of vacant space completed during Q4 was 393,000 rentable sq ft, nearly double the average over the last five quarters [6] - Free rent and rental rate changes on renewed and released space were under pressure, reflecting market realities [6] Market Data and Key Metrics Changes - The company expects occupancy to dip in Q1 2026 due to 1.2 million sq ft of key lease expirations [8] - The company reiterated its year-end 2026 occupancy range of 87.7%-89.3% [7] - The Greater Boston region saw an 11% increase in tenants, marking the first increase in several quarters [33] Company Strategy and Development Direction - The strategic focus for 2026 includes timely execution of plans, maintaining a strong balance sheet, and reducing capital expenditures [4] - The company aims to significantly reduce the size of its pipeline and construction spending needs [13] - The disposition program for 2026 is expected to include a significant component of land, targeting non-core assets [21] Management's Comments on Operating Environment and Future Outlook - Management noted the life science bear market and the challenges posed by regulatory changes and market dynamics [3] - There is cautious optimism regarding venture capital funding, but decision-making remains slow among companies [26] - The company anticipates a recovery in leasing demand but acknowledges the need for more robust public biotech activity [50] Other Important Information - The company achieved general and administrative cost savings of $51.3 million, or 30% compared to the prior year [12] - Realized gains from venture investments were $21 million, down from the previous quarterly average [15] - The company has a strong balance sheet with liquidity of $5.3 billion and a net debt to adjusted EBITDA ratio of 5.7x [16] Q&A Session Summary Question: Impact of VC funding on leasing outlook - Management noted that while there is sustained funding in private biotechnology, the overall environment remains cautious, and decision-making is slower [25][26] Question: Strategy regarding The Fenway office property - Management indicated that retaining The Fenway office property for leasing is specific to that location and not a broader strategy [28] Question: Cap rate trends for dispositions - Management mentioned that cap rates for non-core assets range from mid-sixes to mid-nines, depending on market conditions [31] Question: Leasing pipeline and notable groups - Management highlighted that smaller spaces under 50,000 sq ft are in demand, but there is a lack of activity from public biotech companies [32][33] Question: Guidance for Q4 2026 FFO - Management confirmed that the guidance for Q4 2026 FFO remains at $1.40-$1.60, representing a trough for the year [34][41] Question: Capital allocation priorities - Management stated that the priority is on debt reduction before considering stock buybacks [52]

Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2026 Table of Contents December 31, 2025 | COMPANY HIGHLIGHTS | Page | | Page | | | --- | --- | --- | --- | --- | | Alexandria's Mission and Cluster Model | iii | | | CONFERENCE CALL | | | | | | INFORMATION: | | EARNINGS PRESS RELEASE | | | | Tuesday, January 27, 2026 | | Fourth Quarter and Year Ended December 31, 2025 Financial and | | | | 2:00 p.m. Eastern Time | | Operating Results | 1 | Consolidated Statements of Operations | 8 | 11:00 a.m. Pa ...

Core Insights - The REITs industry has undergone significant changes over the past five years, with a shift from an era of easy capital to a more discerning investment environment in the post-pandemic era [1] Industry Changes - The transition in the REITs sector indicates that investors are now more selective, reflecting a broader trend in investment behavior following the pandemic [1]